# Phase 5 Ethics Review — FINAL_HIGH_END_AUDIT.md

**Reviewer role:** independent deep-research Ethics Reviewer

**Review date:** 2026-07-15

**Artifact reviewed:** `FINAL_HIGH_END_AUDIT.md`

**Verdict:** **CONDITIONAL**
**Critical integrity concerns:** **None**

This is a research-ethics and source-integrity self-check, not legal advice, an
IRB determination, a security certification, or a substitute for review by a
qualified human committee. The underlying audit used repository evidence and
public/verified secondary sources; it did not itself recruit or study people.
Its proposed P0 and P1 activities would, however, collect human-related data
and require the safeguards below before recruitment.

## Executive ethics judgment

The report is unusually disciplined about the difference between software
mechanics, product demand, score validity, legal risk, and evidence. It
correctly blocks own-draft use, authoritative scoring, and public launch; does
not allege a breach or legal violation; preserves plural creative judgment;
requires accessibility; and plainly states that no independent human expert
validated the audit. No fabricated citation, plagiarism signal, secret value,
or weaponizable procedure was found.

Delivery is nevertheless **conditional** because six Major issues are precise
and correctable:

1. the proposed writer studies lack a recorded human-subjects/ethics
   determination and a complete participant-consent floor;
2. the sample-only P0 protects screenplays but does not yet protect the human
   data in recruitment records, verbatim notes, recordings, or willingness-to-
   pay responses;
3. the report's 2026 WGA notification claim is supported by a different
   official WGA page than the cited G12 link;
4. the AI/commissioning/conflict disclosure is accurate but incomplete;
5. the sampling and evaluation blueprint does not yet operationalize cultural,
   geographic, economic, experience-level, and disability inclusion; and
6. the report contains actionable current vulnerability detail but no
   responsible-disclosure handling statement.

None is a Critical integrity violation. The report may proceed to Phase 6
revision; it should not be represented as ethics-cleared until the Major
corrections are incorporated.

## Seven-dimension assessment

| Required dimension | Status | Severity | Ethics judgment |
|---|---|---:|---|
| 1. Human subjects, consent, and sample-only P0 versus own-draft research | **Warn** | Major | The present audit has no new human subjects. Future P0/P1 will collect human-related data. No participant draft in sample P0 lowers IP/confidentiality risk but does not remove consent, privacy, withdrawal, recording, or ethics-determination duties. |
| 2. Confidential screenplay, privacy, and data lifecycle | **Warn** | Major | The report correctly blocks own-draft use and specifies a strong future lifecycle gate. It does not yet define the lifecycle for P0 recruitment and verbatim research notes, nor small-N re-identification controls for P1 drafts/readers. |
| 3. Vulnerable or excluded users and accessibility | **Warn** | Major | The report strongly requires keyboard, screen-reader, WCAG, and representative AT completion for product exposure. Sample P0 materials and recruitment are not yet held to the same accessible and inclusive floor. |
| 4. Legal, regulatory, and professional uncertainty | **Warn** | Major | FTC, NIST, WCAG, EU, and USCO claims are properly bounded and the report disclaims legal conclusions. The WGA 2026 notification claim is real but linked to the 2023-AI-protections page rather than the official 2026 MBA FAQ that contains it. |
| 5. Bias, fairness, and plural creative judgment | **Warn** | Major | Preserving reader disagreement, intent, form, genre, language, abstention, and writer authority is a major strength. The proposed sample/benchmark could still encode English-language, U.S.-industry, expert-convention, and economically privileged norms. |
| 6. Dual use, misuse, and automation reliance | **Warn** | Major; dual-use level **Moderate** | The purpose is defensive. However, exact import-destruction, build-context, rate/fan-out, bearer-session, and logging paths could lower the effort required to exploit a live instance. The report should be handled as coordinated vulnerability material until fixed or disabled. |
| 7. Conflicts, transparency, and AI-assistance disclosure | **Warn** | Major | AI assistance and lack of independent human validation are disclosed. Tool/model/version/date, subagent scope, commissioning/product-owner interest, and the auditor-to-implementer conflict are not yet explicit. |

## Critical issues

**No critical issues.** The AI disclosure is present, citations are authentic,
the one source problem is a correctable link/claim mismatch rather than a
fabricated work or systematic misrepresentation, and no concrete secret or
high-harm operational recipe is disclosed.

## Major conditions and exact corrections

| ID | Target in the report | Exact correction required | Clearance evidence |
|---|---|---|---|
| **ER-M01 — human-subjects determination and consent** | Sections 13–16, especially sample-only P0 at lines 566–568, 585–594, and Stages 0/4 at lines 675–721 | Before recruitment, require a recorded, jurisdiction- and institution-specific determination of whether P0/P1 is human-subjects research. Do not self-declare “exempt.” Where an IRB is applicable, obtain its determination before contact/data collection; where no institutional IRB applies, record independent ethics review and the rationale. The P0 consent floor must state purpose, procedures, data captured, optional recording, foreseeable professional/privacy risks, benefits, voluntariness, withdrawal without penalty, compensation, contacts, retention/deletion, quotation policy, and complaint route. | Dated determination; approved/qualified consent form; facilitator script; no data collected before the decision. |
| **ER-M02 — research-data lifecycle** | Sections 14 and 16; P0's “verbatim evidence” and recruitment provenance at lines 585–594 and 715–721 | Add a P0 data-management plan for contact details, recruitment source, notes, recordings, screen captures, compensation, and follow-up. Default to no recording; require separate consent if recording. Pseudonymize notes, keep the identity key separate, restrict access, set retention/deletion dates, review quotations for deductive identification, and report only aggregates or consented excerpts. For P1, add small-N screenplay/reader re-identification controls, co-author/underlying-rights checks, processor/reader confidentiality, withdrawal consequences after model/aggregate use, and deletion reconciliation across DB/WAL/backups/logs/providers. | A field-level data inventory, access list, retention schedule, deletion test, quotation review rule, and participant-facing notice for the exact study artifact. |
| **ER-M03 — WGA citation integrity** | Section 14, line 637; G12 metadata in the bibliography/register | The 2026 notification/remuneration statement must cite and register the official **“2026 MBA Contract Changes FAQ”** at `https://www.wga.org/contracts/contracts/mba/2026-mba-contract-changes-faq`. Keep the existing `.../know-your-rights/artificial-intelligence` page as a separate source only for 2023 MBA AI protections. Do not use one source ID or anchor to blend the two pages. Preserve the existing qualifier that MBA terms are not universal product law. | Citation resolves to the exact official page and text; bibliography, source register, verification record, and report use distinct metadata/IDs or an explicitly versioned G12a/G12b record. |
| **ER-M04 — AI, commissioning, and conflict disclosure** | Front-matter AI disclosure at line 12 and Section 6 source discussion | Name the AI product/model family and access date; state that AI agents performed repository inspection, command execution, web search, source screening/verification, synthesis, drafting, adversarial review, ethics review, and may implement fixes. State exactly what the human owner did and did not verify. Disclose that the product owner commissioned/authorized an audit of their own repository and has a product interest, and that the same AI workflow may recommend and implement remediation. State external funding/financial relationships if known, or “not independently established.” Add a concise source-incentive note for developer-evaluator and institutional sources (A02, A05, A10–A12, A22–A23, A30, S01). | Revised disclosure is specific, reproducible, and does not imply human expert validation; conflicts and unknowns are explicit. |
| **ER-M05 — inclusion, accessibility, and creative plurality** | P0/P1 protocols and Sections 13–14 | Make accessible consent, stimulus, scheduling, remote participation, breaks, captions/transcripts, keyboard/screen-reader use, and accommodation requests prerequisites for P0—not only for later own-draft exposure. Predeclare recruitment dimensions appropriate to the claim: experience level, professional status, form/genre, geography, language, disability/access needs, and economic constraints; compensate fairly without tying payment or opportunity access to favorable responses. Do not claim representativeness from five purposive sessions. For P1, prevent “expert consensus” from becoming dominant-culture truth: preserve raw dissent, disclose reader demographics/conflicts where lawful and consented, test language/form/genre/experience/geographic slices, include unconventional work, and abstain where a slice lacks support. | Accessible materials and accommodation path; recruitment/sampling matrix; compensation policy; claim language limited to the observed population; slice/disagreement plan with minimum support and abstention rules. |
| **ER-M06 — responsible disclosure and distribution** | Report front matter and delivery notes | Add a handling notice: the audit is for defensive remediation; do not publish current exploit paths or expose a live instance until G-001/G-002/G-005/G-006/G-007/G-017 are fixed, disabled, or otherwise mitigated; remove deployment identifiers and secrets from any shared copy; coordinate disclosure with the owner and preserve evidence. A public edition should summarize risk and remediation without unnecessary reproduction steps. | Handling statement present; distribution list bounded; public/redacted version prepared only after remediation or explicit owner risk acceptance. |

## Minor advisories

1. **ER-m01 — retraction freshness.** The frozen verification found no
   retracted or predatory retained source. Before external publication, repeat
   a current Crossref/publisher/Retraction Watch or equivalent integrity check
   for the journal/conference sources and record the date. This is a freshness
   control, not evidence that any source is problematic.
2. **ER-m02 — geographic scope language.** Rename “industry benchmark” or add
   an adjacent limitation stating that the reviewed competitor/professional
   evidence is predominantly English-language and U.S./Western-market-facing.
   It cannot represent global screenwriting labor, copyright, cultural practice,
   pricing, accessibility, or professional norms.
3. **ER-m03 — reported professional status.** Where A02 or S01 participants are
   called professional screenwriters, attribute that status to the study's
   recruitment/reporting unless credentials were independently verified.
4. **ER-m04 — copyrighted research material.** The report mostly paraphrases
   and does not reproduce scripts or long protected passages. Preserve that
   practice in P1 artifacts; do not publish screenplay excerpts, reader notes,
   or benchmark fixtures beyond the rights grant.

## Detailed dimension findings

### 1. Human subjects and consent

The audit itself inspected software, documents, public product pages, and
published literature; no new person was recruited, intervened upon, or
identified. Human-subjects review is therefore not applicable to the completed
repository audit as such.

The proposed research is different. Sample-only P0 collects comprehension,
objections, curiosity, intention, willingness to continue/pay, recruitment
provenance, and verbatim statements. These are data about people even though no
participant screenplay is uploaded. The report must not imply that “no draft”
means “no ethics duties.” Whether the work is regulated human-subjects research
depends on purpose, institution, geography, dissemination, and local rules; a
qualified determination must precede recruitment.

Own-draft and P1 work increase risk materially: unpublished creative work,
professional reputation, contractual/underlying rights, co-authorship, reader
identity, and potentially identifiable qualitative rationales enter the data
flow. The report correctly blocks that lane and requires rights, compensation,
withdrawal/deletion, provider/human access, and expiry. ER-M01 and ER-M02 make
those protections operational rather than aspirational.

### 2. Confidential screenplay, privacy, and lifecycle

The report's strongest ethical choice is its noncompensable own-draft gate. It
does not claim a breach; it distinguishes quick and deep processing; requires
provider-specific consent, data/subprocessor maps, transfer manifests,
retention/deletion, backups/logs, and qualified review; and rejects “private/no
training” as an architectural assumption. FTC privacy guidance is represented
as a risk/substantiation source, not a finding of violation.

The remaining gap is research operations. Small-N screenwriter samples are
easy to re-identify from project history, genre, employer, experience, or
quotations. Verbatim P0 notes can expose professional views even without draft
text. P1 must also distinguish a writer's authority to participate from rights
held by co-writers, producers, studios, estates, or underlying-work owners.
ER-M02 is required before any human data is collected.

### 3. Vulnerable or excluded users and accessibility

Screenwriters are not categorically a vulnerable population. Individual
participants can nevertheless face power, disability, language, employment,
immigration, economic, or opportunity-access pressures. Emerging and
economically precarious writers may perceive participation, praise, or score
agreement as connected to access. Payment and future opportunities must never
depend on favorable responses.

The report appropriately rejects technical WCAG conformance as complete lived
usability and requires representative AT completion. That standard must begin
with P0 consent and stimulus, not only after own-draft gating. Recruitment and
claim scope must also avoid turning a small, founder-adjacent, English-language
sample into “writers” or “industry” generally.

### 4. Legal, regulatory, and professional uncertainty

The legal framing is generally careful:

- FTC sources are called guidance, and the report explicitly says it has not
  found a violation.
- NIST AI 600-1 is used for lifecycle risk governance, not certification.
- WCAG 2.2 is used for testable accessibility behavior, not a claim of legal
  conformance or lived usability.
- the EU AI Act is described with the general 2026-08-02 application date and
  explicit actor/feature/date uncertainty;
- USCO Part 2 is correctly described as administrative guidance rather than a
  court judgment or global rule, and Part 3 is treated as pre-publication at
  the frozen date; and
- WGA terms are correctly bounded to the applicable professional agreement.

The material exception is source precision: the current G12 hyperlink is the
2023 protections page, while the quoted 2026 notice rule appears on the
official 2026 MBA FAQ. The claim is not fabricated, but the cited page does not
support that exact proposition. ER-M03 must be fixed. All applicability
analysis remains for qualified counsel based on the actual entity, deployment,
providers, geography, contracts, and feature set.

### 5. Bias, fairness, and plural creative judgment

The report resists several major fairness failures: it withholds objective
quality authority, captures writer intent and form, preserves reader
disagreement, separates model/human/observation sources, uses abstention, avoids
one confidence percentage, and proposes genre/form/language/experience slices.
It also warns that expert consensus can encode shared convention and bias.

The operational blueprint is still incomplete. “Experienced readers” can
encode dominant commercial taste; English-language datasets can penalize other
traditions; feature-length norms can misclassify shorts, pilots, excerpts, or
experimental structure; accessibility exclusion can make telemetry falsely
homogeneous. The benchmark needs claim-limited sampling, plural readers and
communities, raw disagreement, subgroup minimums, and abstention where support
is absent. Protected-characteristic collection should occur only when lawful,
consented, necessary, and governed; demographic fields must not become craft
judgment inputs by default.

### 6. Dual use, misuse, and automation reliance

Automation-reliance treatment is strong. The report rejects maximal trust,
persuasive scalar authority, engine-score self-confirmation, and automatic
human–AI synergy. It requires challenge, override, reversibility, disagreement,
independent outcomes, provider lineage, and abstention.

Dual-use risk is **Moderate**, not because security research is objectionable,
but because this internal report identifies currently reachable routes,
failure order, schema behavior, bearer-capability limits, and build/log paths.
Those details could assist misuse against an exposed deployment. No secret,
token, personal datum, screenplay, or high-harm recipe is present, so a Critical
or High classification is not warranted. ER-M06 supplies the proportionate
handling safeguard.

### 7. Conflicts, transparency, and AI assistance

The disclosure is truthful in important respects: it says AI supported
inspection, testing, research, verification, synthesis, and drafting; the owner
set scope; and no independent screenwriter, lawyer, security assessor, or
editor validated the conclusions. It does not pass AI output off as independent
human expertise.

For reproducibility and conflict transparency, the disclosure must also name
the AI tool/model family and date, describe delegated agents and command/web
execution, disclose the product-owner commissioning interest, and state that
the same AI workflow may implement its own recommendations. The report should
bring forward the most decision-relevant source incentives already documented
in the verification artifact, especially developer-evaluator studies and
Microsoft/IBM or method-advocacy relationships. These are conflicts to manage,
not evidence of misconduct.

## External-reference integrity check

### Method and coverage

- **Unique external references used by the report:** 27.
- **Ethics/source-representation checked:** 27/27 (**100%**), exceeding the
  required 50%.
- **Existence check:** all 19 DOI-bearing works used by the report resolved
  through Crossref during this review, including S01 and NIST AI 600-1. A10 was
  checked through the ACL record. Official sources were checked against their
  primary pages and the Phase 2 verification record.
- **Official-page refresh:** FTC G08, WCAG, USCO's AI landing page, the 2023 WGA
  AI page, and the 2026 WGA MBA FAQ were re-opened. FTC G07 returned 403 to the
  automated client, consistent with the earlier verification; its title and
  bounded claim remain officially corroborated. EUR-Lex's automated response
  did not return the full text in this client, so G11 relies on the recorded
  official primary-law verification rather than a new content scrape.
- **Retraction/integrity:** the frozen source verification found no retained
  retracted, fabricated, or predatory source. No contrary signal arose here.
  A current comprehensive retraction-database refresh remains Minor advisory
  ER-m01.
- **Self-citation:** no report-author academic self-citation was identifiable.
  Product-owner and AI-workflow conflicts are handled separately in ER-M04.

### Per-source claim-context audit

| IDs checked | Report use | Result |
|---|---|---|
| **S01** | Short-term screenplay-reflection plausibility; 9 formative/14 evaluative participants; no human-coverage, artifact-quality, demand, or longitudinal proof | **Pass.** Supplemental status, developer-evaluator/Microsoft incentives, AI comparator, and outcome limits are stated. “Professional” status should remain attributed to the authors (ER-m03). |
| **A02** | Interviews with 23 screenwriters; plural practices/desired AI roles; not product demand | **Pass.** Population, qualitative scope, and transfer limit are accurate. |
| **A04, A05** | Creative-writing support needs; positive experience need not imply better artifact | **Pass.** The report does not transfer these studies into screenplay efficacy. |
| **A10, A11, A12** | Weakness, disagreement, prompt sensitivity, and perturbation limits in generated-story evaluation | **Pass.** The report expressly says these findings are not direct evidence that STORYMACHINE fails on real screenplays. Benchmark-creator incentives remain documented. |
| **A13, A15** | Rating aggregation can reverse preference; human and LLM judgment biases | **Pass.** Bounded to tested judgment tasks; no claim that screenplay-specific biases are exhaustively mapped. |
| **A18, A19** | Validity concerns interpretation/use; reliability statistic must fit design | **Pass.** Foundational/methodological use is appropriate; neither source is treated as product efficacy. |
| **A22, A23** | Domain expertise can affect rating consistency | **Pass with caution.** Report preserves disagreement and notes expert consensus may encode convention; it does not equate agreement with validity. |
| **A24, A25** | Appropriate reliance and fragmented trust/reliance/calibration constructs | **Pass.** No particular STORYMACHINE interface is claimed validated. |
| **A27, A28** | Cognitive forcing/preferences and verification cost/incentive effects | **Pass.** Artificial-task transfer is used as a design burden, not writer outcome proof. |
| **A26, A30** | Human–AI augmentation does not guarantee better-member synergy; complementarity depends on asymmetry | **Pass.** The report requires independent-human, machine, and assisted arms rather than claiming synergy. IBM/developer incentives should be visible under ER-M04. |
| **G02, G04** | Lifecycle GAI governance and API risk taxonomy | **Pass.** NIST/OWASP are not presented as certification, prevalence evidence, or proof of STORYMACHINE controls. |
| **G06** | WCAG 2.2 testable accessibility criteria | **Pass.** The report explicitly says conformance is not complete lived usability. |
| **G07, G08** | AI-claim substantiation and privacy/confidentiality commitments | **Pass.** Used as regulator guidance/risk identification, not a legal violation or complete privacy-law map. |
| **G09** | USCO Part 2 copyrightability position | **Pass.** Correctly characterized as administrative guidance, not a court/global rule. |
| **G11** | EU AI Act general 2026-08-02 application date and staged/scope-specific uncertainty | **Pass.** The report does not classify the product or give an applicability conclusion. Refresh after the application date and material feature/provider changes. |
| **G12** | WGA professional context and 2026 MBA notification rule | **Correction required (ER-M03).** The proposition is supported by the official 2026 MBA FAQ, but the report links/anchors the distinct 2023 MBA AI-protections page. |

**Reference outcome:** 26 references are ethically and contextually represented;
one authentic source claim needs exact-link/metadata correction. No fabricated
or retracted report reference was found.

## AI disclosure verification

- [x] Disclosure statement present.
- [x] Search, inspection, testing, synthesis, source verification, and drafting
  roles are described at a high level.
- [x] Lack of independent human screenwriter/legal/security/editor validation
  is explicit.
- [ ] AI product/model family, version/date, delegated-agent scope, and material
  tool execution are named.
- [ ] Product-owner commissioning interest and auditor/implementer conflict are
  explicit.
- [ ] Decision-relevant source incentives are summarized in the report rather
  than only in supporting artifacts.

## Recommended responsible-use statement

> **Responsible use and handling.** This audit is intended to help the project
> owner identify, disable, and repair content-integrity, confidentiality,
> evaluation, and accessibility risks. It contains current technical weakness
> details that could be misused against an exposed deployment. Until the named
> critical paths are fixed, disabled, or mitigated, keep the detailed version
> to people responsible for remediation; remove secrets and deployment-specific
> identifiers from shared copies; coordinate any external disclosure with the
> owner; and publish only the minimum technical detail needed to explain risk
> and verify remediation. Do not use the report's score or product-future
> analysis to judge writers, allocate opportunity, or claim screenplay quality.

## Ethics clearance notes

The report's product judgment is ethically preferable to its current runtime
surface: it withholds authority, preserves writer agency, treats confidentiality
and recovery as noncompensable, and makes negative/ambiguous P0 outcomes valid
stop results. The conditional verdict does not authorize own-draft research or
public launch. It authorizes one report-revision loop and, after ER-M01 through
ER-M06 are satisfied, delivery as a bounded internal audit.

## Ethics decision log

No user override or completed corrective action was recorded during this
independent review. ER-M01 through ER-M06 are returned to the Phase 6 compiler
for revision. If any condition is intentionally overridden, the final audit
record must identify the item, decision-maker, date, reasoning, accepted
residual risk, and expiry/revisit trigger.

## Post-revision disposition — Phase 6 Cycle 1

**Verdict: CLEARED for delivery as a bounded internal audit.** This clearance
does **not** clear P0 recruitment, own-draft handling, P1 research, product
fielding, deployment, authoritative scoring, or public launch.

| Condition | Cycle-1 disposition |
|---|---|
| **ER-M01** | **Satisfied in the report.** Recruitment is gated on a jurisdiction/institution-specific human-subjects or ethics determination; self-declared exemption is prohibited; an independent ethics review/rationale is required where no institutional IRB applies; the consent floor is complete. The actual determination and consent artifact remain future operational prerequisites. |
| **ER-M02** | **Satisfied in the report.** P0 now has a no-recording default, field inventory, pseudonymization/separate identity key, access, retention/deletion, quotation, and deletion-test controls. P1 adds co-rights, small-N re-identification, confidentiality, withdrawal-consequence, and DB/WAL/backup/log/provider deletion reconciliation. |
| **ER-M03** | **Satisfied.** S02 is the exact official 2026 MBA FAQ; G12 remains the distinct 2023 protections page. The report, bibliography, source register, verification record, and Amendment 03 preserve the negotiated-agreement scope and make no STORYMACHINE applicability claim. |
| **ER-M04** | **Satisfied.** The front matter names OpenAI Codex, a GPT-5-based delegated-agent workflow, dates, agent/tool roles, owner commissioning and product interest, auditor/implementer overlap, lack of independent human validation, unknown external financial relationships, and decision-relevant source incentives. |
| **ER-M05** | **Satisfied in the report.** Accessible consent/stimulus, keyboard/screen-reader materials, captions, remote participation, breaks, accommodations, fair compensation, recruitment dimensions, non-representativeness, plural readers, raw dissent, unconventional work, slices, and abstention are explicit gates. |
| **ER-M06** | **Satisfied.** The defensive-handling notice restricts detailed distribution until named vulnerability paths are fixed/disabled/mitigated, forbids exposing a live instance, requires secret/identifier removal and coordinated disclosure, and bounds any public edition. |

S02 was rechecked against the official source/control artifacts. The revised
report makes no efficacy, compliance, breach, committed-demand, global-
representativeness, professional-credential, product-selection, or launch
claim beyond the evidence. Sample P0 is correctly limited to directional
pre-behavioral evidence, and all participant-data controls are gates rather
than claims that an ethics review or consent process has already occurred.

**Remaining exact issues:**

1. **Minor traceability, non-blocking:** `PHASE_3_TRUTH_REGISTRY.md` row L-04
   still cites `PHASE_2_TWELVE_PERSPECTIVES.md:891-902` and the pre-amendment
   `PHASE_2_SOURCE_VERIFICATION.md:315-337` block for the 2026 WGA proposition.
   Point L-04 directly to S02, `PROTOCOL_AMENDMENT_03.md`, and
   `PHASE_2_SOURCE_VERIFICATION.md:457-490`. This does not alter the claim or
   clearance; it prevents future agents from following an obsolete evidence
   pointer.
2. The actual human-subjects/ethics determination, consent materials,
   research-data plan, accommodation path, and compensation protocol do not
   yet exist. The report accurately treats them as pre-recruitment evidence
   gates; clearance of this document must not be cited as clearance to recruit.
3. A fresh publisher/Crossref/retraction-integrity check remains required
   before external publication, as the revised report now states.

No user override was used. All prior Major conditions were accepted and
resolved in the document; the residual items are an exact supporting-artifact
pointer and future operational gates, not unresolved report-integrity defects.

## Final Cycle 2 disposition

**Verdict: CLEARED for delivery as a bounded internal audit; no ethics
blocker remains.** `PHASE_3_TRUTH_REGISTRY.md` L-04 now points directly to
supplemental source S02, `PROTOCOL_AMENDMENT_03.md`, and the dedicated
Supplemental S02 verification section. The final report continues to cite the
official 2026 WGA MBA FAQ for the bounded 2026 proposition and keeps G12
separate for 2023 MBA protections. The prior Cycle 1 clearance therefore
stands without qualification beyond the already stated operational gates:
this document does not clear recruitment, own-draft/P1 research, product
fielding, authoritative scoring, deployment, or public launch.
